|
|
|
Volumn 26, Issue 2, 2008, Pages 51-61
|
|
Drug-drug interactions in systemic cancer therapy;Klinisch relevante pharmakokinetische interaktionen von und mit zytostatika
|
|
Author keywords
Anticancer agents; Drug drug interactions; Pharmacokinetic interactions; Tyrosine kinase inhibitors
|
|
Indexed keywords
ALEMTUZUMAB;
ANTHRACYCLINE;
ANTIMETABOLITE;
BEVACIZUMAB;
BORTEZOMIB;
BUSULFAN;
CAPECITABINE;
CARBOPLATIN;
CETUXIMAB;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTOCHROME P450;
CYTOCHROME P450 1A2;
CYTOCHROME P450 2B6;
CYTOCHROME P450 2C19;
CYTOCHROME P450 2C9;
CYTOCHROME P450 2D6;
CYTOCHROME P450 3A4;
CYTOCHROME P450 3A5;
CYTOSTATIC AGENT;
DACARBAZINE;
DASATINIB;
DETIMEDAC;
DOCETAXEL;
DOXORUBICIN;
EPIRUBICIN;
ERLOTINIB;
ETOPOSIDE;
FLUDARABINE PHOSPHATE;
FLUOROURACIL;
FOLIC ACID ANTAGONIST;
GEMCITABINE;
IFOSFAMIDE;
IMATINIB;
IRINOTECAN;
LAPATINIB;
METHOTREXATE;
NAVELBINE;
NELARABINE;
NILOTINIB;
OXALIPLATIN;
PACLITAXEL;
PEMETREXED;
PROTEIN TYROSINE KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
RITUXIMAB;
SORAFENIB;
SUNITINIB;
TEMOZOLOMIDE;
TEMSIROLIMUS;
THIOTEPA;
TOPOTECAN;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
CANCER CHEMOTHERAPY;
DRUG INTERACTION;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
DRUG TRANSFORMATION;
HUMAN;
PHARMACODYNAMICS;
PHARMACOKINETICS;
REVIEW;
|
|
EID: 66949131891
PISSN: 07236913
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (33)
|
